Cargando…
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group
It is increasingly common in oncology practice to perform tumour sequencing using large cancer panels. For pathogenic sequence variants in cancer susceptibility genes identified on tumour-only sequencing, it is often unclear whether they are of somatic or constitutional (germline) origin. There is w...
Autores principales: | Mandelker, D, Donoghue, M, Talukdar, S, Bandlamudi, C, Srinivasan, P, Vivek, M, Jezdic, S, Hanson, H, Snape, K, Kulkarni, A, Hawkes, L, Douillard, J -Y, Wallace, S E, Rial-Sebbag, E, Meric-Bersntam, F, George, A, Chubb, D, Loveday, C, Ladanyi, M, Berger, M F, Taylor, B S, Turnbull, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683854/ https://www.ncbi.nlm.nih.gov/pubmed/31050713 http://dx.doi.org/10.1093/annonc/mdz136 |
Ejemplares similares
-
Erratum to ‘Germline-focussed analysis of tumour-only sequencing:
recommendations from the ESMO Precision Medicine Working Group’: [Annals of Oncology 30 (2019) 1221–1231]
por: Mandelker, D., et al.
Publicado: (2021) -
The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
por: Saloustros, Emmanouil, et al.
Publicado: (2017) -
ESMO Copenhagen 2016: a lung cancer ‘grand cru’
por: Douillard, Jean-Yves
Publicado: (2017) -
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016
por: Dittrich, C., et al.
Publicado: (2016) -
Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)